Damian T. Lismore
Director/Board Member presso CONTROL BIONICS LIMITED
Profilo
Damian T.
Lismore is currently a Non-Executive Director at Control Bionics Ltd., a Member at the Australian Institute of Co. Directors, a Member at The Institute of Chartered Accountants in Australia, a Member at Chartered Accountants Australia & New Zealand, and the Chief Financial Officer at Scout Bio, Inc. Previously, Mr. Lismore held positions as a Non-Executive Director at LBT Innovations Ltd.
from 2019 to 2023, Managing Director at MNT Innovations Pty Ltd.
from 2002 to 2005, Chief Finance & Accounting Officer at Nexvet Biopharma Plc from 2013 to 2017, Group Financial Controller and GM-Buying & Finance at Sigma Co. Ltd.
in 2000, CFO, Secretary & Head-Investor Relations at Biota Holdings Pty Ltd.
from 2005 to 2013, General Manager at Analytica Ltd.
in 2002, Senior Manager at PricewaterhouseCoopers (Australia) from 1986 to 1996, and Chief Financial Officer at Nexvet Australia Pty Ltd.
from 2013 to 2017.
Mr. Lismore also served as the Chief Financial Officer & Head-Investor Relations at Aviragen Therapeutics, Inc.Mr. Lismore obtained an undergraduate degree from the University of Ulster.
Posizioni attive di Damian T. Lismore
| Società | Posizione | Inizio |
|---|---|---|
| CONTROL BIONICS LIMITED | Director/Board Member | 01/09/2020 |
| The Institute of Chartered Accountants in Australia | Corporate Officer/Principal | - |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
Chartered Accountants Australia & New Zealand
 Chartered Accountants Australia & New Zealand Miscellaneous Commercial ServicesCommercial Services Chartered Accountants Australia & New Zealand is an association for chartered accountants that provides accounting services. The non-profit company is based in Auckland, New Zealand. | Corporate Officer/Principal | - |
Scout Bio, Inc.
 Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Scout Bio, Inc. operates as a biotechnology company that focuses on the innovation of pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. It also specializes in gene therapy, veterinary product development and biotechnology investment. The company was founded by James M. Wilson in 2016 and is headquartered in Philadelphia, PA. | Director of Finance/CFO | - |
Precedenti posizioni note di Damian T. Lismore
| Società | Posizione | Fine |
|---|---|---|
| LBT INNOVATIONS LIMITED | Director/Board Member | 29/11/2023 |
Nexvet Australia Pty Ltd.
 Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Director of Finance/CFO | 01/09/2017 |
| NEXVET BIOPHARMA PUBLIC LIMITED CO | Director of Finance/CFO | 31/07/2017 |
| BIOTA HOLDINGS LTD. | Director of Finance/CFO | - |
| ░░░ ░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formazione di Damian T. Lismore
| University of Ulster | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| LBT INNOVATIONS LIMITED | Health Technology |
| CONTROL BIONICS LIMITED | Technology Services |
| Aziende private | 12 |
|---|---|
Nexvet Biopharma Plc
 Nexvet Biopharma Plc Pharmaceuticals: MajorHealth Technology Nexvet Biopharma Plc engaged in the provision of integrated biopharmaceutical business. It focused on transforming the therapeutic market for companion animals, such as dogs and cats, by developing and commercializing novel, species-specific biologics. The company was founded in September 2014 and was headquartered in Dublin, Ireland. | Health Technology |
Sigma Co. Ltd.
 Sigma Co. Ltd. Pharmaceuticals: MajorHealth Technology Sigma Ltd. is one of the leading Australian healthcare company that operates in pharmaceutical industry through its activities as a manufacturer, marketer, wholesaler and retailer. | Health Technology |
Biota Holdings Pty Ltd.
 Biota Holdings Pty Ltd. Pharmaceuticals: MajorHealth Technology Biota Holdings Pty Ltd. operates as an anti infective drug development firm. The company was founded on October 2, 1985 and is headquartered in Notting Hil, Australia. | Health Technology |
Analytica Ltd.
 Analytica Ltd. Medical SpecialtiesHealth Technology Analytica Ltd. engages in the design development, and supply of class 1 and class 2 medical devices. It operates through the following segment: Medical Devices and Corporate. The Medical Devices segment is consist of AutoStart Burette, PeriCoach, and ELF 2. The Corporate segment includes all other operations including the administration, and associated listed public company expenditure. The company is headquartered in Brisbane, Australia. | Health Technology |
PricewaterhouseCoopers (Australia)
 PricewaterhouseCoopers (Australia) Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers (Australia) provides accounting and legal services. It offers asset management, consulting, indigenous consulting, and tax services. The company was founded in 1998 and is headquartered in Barangaroo, Australia. | Commercial Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
| MNT Innovations Pty Ltd. | |
Nexvet Australia Pty Ltd.
Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Health Technology |
Aviragen Therapeutics, Inc.
 Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Health Technology |
Scout Bio, Inc.
Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Scout Bio, Inc. operates as a biotechnology company that focuses on the innovation of pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. It also specializes in gene therapy, veterinary product development and biotechnology investment. The company was founded by James M. Wilson in 2016 and is headquartered in Philadelphia, PA. | Health Technology |
| The Institute of Chartered Accountants in Australia | |
Chartered Accountants Australia & New Zealand
Chartered Accountants Australia & New Zealand Miscellaneous Commercial ServicesCommercial Services Chartered Accountants Australia & New Zealand is an association for chartered accountants that provides accounting services. The non-profit company is based in Auckland, New Zealand. | Commercial Services |
- Borsa valori
- Insiders
- Damian T. Lismore
